0Suppliers
2Customers
1Debt Items
20Related Chains

CI&T Inc. Suppliers

No suppliers on recordCI&T Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

CI&T Inc. Customers

TickerNameConfidenceEvidence
GLOBAL-COMPANY-BASED-IN-NORTH-AMERICA-WITHIN-THE GLOBAL-COMPANY-BASED-IN-NORTH-AMERICA-WITHIN-THE 90% In 2023 , our top client was a global company based in North America within the consumer goods sector, which accounted for 8.3 % of our Revenue.
MARKETING-LTDA-TRANSPIRE-TECHNOLOGY-PTY-LTD MARKETING-LTDA-TRANSPIRE-TECHNOLOGY-PTY-LTD 85% der the symbol “CINT” in connection with our initial public offering. Since then , we completed a number of acquisitions, including Somo Global Ltd, Box 1824 Planejamento e Marketing Ltda., Transpire…

CI&T Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CINT-DEBT Debt stack $128.3M 90% Market cache reports total debt of $128.3M.

CI&T Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CI&T Inc..

CI&T Inc. Ownership

HolderNameConfidenceEvidence
CINT-OWNER-ADVENT-INTERNATIONAL-L-P Advent International, L.P. 90% 13F overlay lists Advent International, L.P. as top holder; 39 tracked holders.

CI&T Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DIS The Walt Disney Company 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
FORR Forrester Research, Inc. 100.00 2
BBVA Banco Bilbao Vizcaya Argentaria, S.A. 100.00 2
CTSH Cognizant Technology Solutions Corporation 100.00 1 ['receiving']
CLGN CollPlant Biotechnologies Ltd. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
DAVA Endava plc 100.00 1 ['receiving']
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
GDYN Grid Dynamics Holdings, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
TRIB Trinity Biotech plc 100.00 2